drugset / Trial / NCT02161965

Vascular CalcIfiCation and sTiffness Induced by ORal antIcoAgulation

NCT02161965

Phase 4 Completed 51 enrolled University Hospital, Angers
RandomizedParallel-groupSingle-blindTreatment

Summary

The VICTORIA Study (Vascular CalcIfiCation and sTiffness induced by ORal antIcoAgulation) is a comparative, parallel, prospective, controlled and randomized study of the structural and functional impact of rivaroxaban versus anti-vitamin K drugs on the arterial vasculature.

Timeline

Start
2013-05-21
Primary completion
2016-12-31
Completion
2018-02-16

Drugs

EvaluationDrugModalityDoseRoute
Comparator Fluindione Small molecule Oral
Subject Rivaroxaban Other / unclassified 15 mg Oral
Subject Rivaroxaban Other / unclassified 20 mg Oral
Comparator Warfarin Small molecule Oral